About Taiwan Bio
Taiwan Bio is dedicated to driving innovation and expanding access to cell therapies. Through our FAST CGT platform, we reduce costs, enhance efficacy, accelerate development, and streamline production, setting new milestones in the treatment of chronic and immune-related diseases. Originating in Taiwan, our technology is now expanding globally through strategic collaborations with leading U.S. universities and research institutions, fostering a robust cell therapy ecosystem.
With our unique TDM business model, we provide comprehensive support for cell therapy products in the preclinical and early clinical stages, covering everything from R&D to manufacturing. This approach ensures that cutting-edge cell therapies reach more patients, paving the way for a future free from chronic diseases.
VIEW MORE
With our unique TDM business model, we provide comprehensive support for cell therapy products in the preclinical and early clinical stages, covering everything from R&D to manufacturing. This approach ensures that cutting-edge cell therapies reach more patients, paving the way for a future free from chronic diseases.
Our Specialties
Next-generation cell therapy development
Using the FAST CGT platform, we are building a new drug development database for cell therapies, combining cell engineering technologies to enhance cell functions, and focusing on breakthroughs in the treatment of severe chronic diseases.
Therapeutic Design and Manufacturing Services Specializing in Cellular Therapies
Harnessing the core strengths of the FAST CGT platform and our unique Therapeutics Design & Manufacturing (TDM) business model, we provide comprehensive, one-stop services for cell therapy companies in the preclinical and early clinical stages.
Core Technologies
The FAST CGT platform integrates big data analysis, transgene design, cell engineering, gene modification, and automated manufacturing to lower cell therapy manufacturing costs, enhance efficacy, accelerate development, and shorten production cycles. By addressing key industry challenges with precision and efficiency, the platform drives innovation and broader adoption of cell therapies, supporting the sustainable growth of the global cell therapy industry.
Our Vision
Bring the benefits of cell therapy to patients worldwide and step together into a new era of better health and a future free from chronic diseases.
